Effect of Commonly Prescribed Liquid Medications on Streptococcus mutans Biofilm. An in vitro study

Objective: This study addressed the effect of pediatric liquid antibiotic medications on Streptococcus mutans UA159. These suspensions commonly contain sugars such as sucrose to make them more palatable for children. The study was designed to evaluate the effects of oral liquid antibiotics on Streptococcus mutans growth and biofilm formation. Study Design: A 24 hour culture of S. mutans was treated with various concentrations of liquid medications commonly prescribed to children for odontogenic or fungal infections– amoxicillin, penicillin VK, clindamycin, and nystatin. The study was conducted in sterile 96-well flat bottom microtiter plates. The minimum inhibitory and biofilm inhibitory concentrations (MIC/MBIC) of S. mutans were determined for each medication. S. mutans was cultured with and without the test drugs, the amount of total growth measured, the biofilms washed, fixed, and stained with crystal violet. The absorbance was determined to evaluate biofilm formation. Results: Higher concentrations of amoxicillin, penicillin VK and clindamycin had decreased biofilm and overall growth than the control. The MICs were 1:2,560 (1.95 ug/ml), 1:2,560 (1.95 ug/ml) and 1:40 (9.375 ug/ml), while the MBIC were 1:640 (7.8 ug/ml), 1:1,280 (3.9 ug/ml) and 1:20 (18.75 ug/ml), respectively. Lower concentrations provided increased biofilm and overall growth. Nystatin induced significantly more biofilm and overall growth than the control at all concentrations. Conclusion: At high concentrations, approximately at the levels expected to be present in the oral cavity of children, amoxicillin, penicillin, and clindamycin inhibited S. mutans biofilm and overall growth due to their antibiotic activity, while at lower concentrations the three antibiotics demonstrated an increase in biofilm and growth. The increase in S. mutans biofilm and overall growth is most likely attributed to the sugar content in the medications. Nystatin provided an increase in biofilm and growth at each concentration tested.

pediatric medications, early childhood caries (ECC), S. mutans, biofilm

1. Subramaniam P, NN. Cariogenic potential of pediatric liquid medica-ments: an in-vitro study. J Clin Pediatr Dent. 36: 357-62, 2012.

2. Forssten S, Bjorklund M, and Ouwehand A. Streptococcus mutans, caries and simulation models. Nutrients. 2: 290-98, 2010.

3. Pierro S, Abdelnur VS, Maia JP, Trugo LC. Free sugar concentration and pH of paediatric medicines in Brazil. Community Dent Health. 22:180-83, 2005.

4. Sharma A, Deshpande S. Effect of sucrose in different commonly used pediatric medicines on plaque pH in human subjects. J Indian Soc Pedod Prev Dent. 29: 144-8, 2011.

5. Leme AF, Koo H, Bellato CM, Bedi G, Cury JA. The role of sucrose in cariogenic dental biofilm formation: new insight. J Dent Res. 85: 878-87, 2006.

6. Campbell R, Zinner D. Effect of certain dietary sugars on hamster caries. J of Nutr. 100:11-20, 1970.

7. Wenersson J, Danielsson NL, Einarson S, Hernell O, Johansson I. Effects of human milk on adhesion of Streptococcus mutans to saliva-coated hydroxyapatite in vitro. Caries Res. 40: 412-7, 2006.

8. Leme AF, Koo H, Bellato CM, Bedi G, Cury JA. The role of sucrose in cariogenic dental biofilm formation: new insight. J Dent Res. 85: 878-87, 2006.

9. Huang R, Mingyun L, Gregory RL. Bacterial interactions in dental biofilm. Virulence. 2.5: 435-44, 2011.

10. Huang R, Li M, Gregory RL. Effect of nicotine on growth and metabo-lism of Streptococcus mutans. Eur J Oral Sci. 120: 319-25, 2011.

11. Dean JA, Avery DR, McDonald RE. McDonald and Avery’s Dentistry for the Child and Adolescent. Maryland Heights, Missouri; 182, 2011.

12. American Academy of Pediatric Dentistry Guideline on Infant Oral Health Care. AAPD Reference manual. Pediatr Dent. 35: 132-6, 2012.

13. Palmer CA, Kent R, Loo CY. Diet and caries-associated bacteria in severe early childhood caries. J Dent Res. 89:1224-9, 2010.

14. Ramos-Gomez F, Huang G, Masouredis C. Prevention and treatment costs of infant caries in northern california. J Pub Heal Dent. 59: 192-97, 1999.

15. Ribeiro NM, Ribeiro MA. Breastfeeding and early childhood caries: a critical review. J de Pediatr (Rio J). 2004 Nov; 80(5 Suppl): S199-210.

16. Ajdic D, McShan WM, McLaughlin RE, Savic G, Chang J, Carson MB. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A. 99: 14434-14439, 2002.

17. Athlone Laboratories, written communication, October, 2013.

18. Subramaniam P, NN. Cariogenic Potential of Pediatric Liquid Medica-ments- An in vitro Study. J Clin Pediatr Dent. 36: 357-62, 2012.

19. Pfizer Laboratory, written communication, October, 2013.

20. Walgreens Pharmacy, written communication, October 2013.

21. Pierce C, Uppuluri P, Tristan A, Wormley F, Mowat E, Ramage G, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 3.9: 1494-500, 2008.

22. Drury TF, Horowitz AM, Ismail AI, Maertens MP, Rozier RG, and Selwitz RH. Diagnosing and reporting early childhood caries for research purposes: a report of a workshop sponsored by the national institute of dental and craniofacial research, the health resources and services admin-istration, and the health care financing administration. J Public Health Dent. 59.3: 192-97, 1999.

23. Jarvinen H, Tenovuo J, Huovinen P. In vitro susceptibility of Strepto-coccus mutans to chlorhexidine and six other antimicrobial agents. Anti-microb Agents Chemother. 37: 1158-1159. 1993.

24. Teng LJ, Hsueh PR, Chen YC, Ho SH, Luh KT. Antimicrobial suscep-tibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother. 41: 621-627. 1998.